Applied Genetic Technologies Corporation reported a net loss of $8.1 million, or $0.45 per share, in its third fiscal quarter compared with a net loss of $1.2 million, or $0.07 per share, in the same period of 2017.
Revenues for the quarter totaled $3.6 million compared with $8.4 million in the same time period a year ago, according to a press release.
Research and development costs increased from $6.3 million to $7.4 million for the quarter, while general and administrative costs increased from $2.9 million to $3.9 million.
AGTC had (Read more...)
Uncategorized